ZINC69391, another virtually screened RAC1-GEF blocking agent, impedes RAC1-TIAM1 binding and efficiently inhibits highly metastatic breast cancer cell proliferation, cycle progression and migration, showing anti-metastatic effects in mouse models. The gene discussed is RAC1; the disease is breast cancer.